10.46243/jst.2021.v6.i3.pp17-20 registered
A Review of Investigational Treatments for Covid-19 - Zinc Supplementary
Resolves to https://www.jst.org.in/index.php/pub/article/view/792
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2021.v6.i3.pp17-20
Registered 29 Sep 2026 via crossref · record version 2 · last change 30 Sep 2026, 12:00 AM · record sha256 4835220c4b03711a…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
A Review of Investigational Treatments for Covid-19 - Zinc Supplementary (PrincipalTitle · en)
Published 2021-05-20
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 06 · issue 03 · pages 17–20
Agents
- Dr. K. Deepa (author)
- Dr. Preethi Anand (author)
- Dr. S. Kothai (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2021.v6.i3.pp17-20
Abstract · en
Zinc (Zn) is an investigational agent against Coronavirus disease 2019 (COVID-19) and has known protective and medicinal function for other infections. Due to the quick increase and vast number of pretentious individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are extremely warranted. Zn deficiency is associated with lower survival among older patients with pneumonia and predisposes to other viral infections. Zn supplement has an efficacious against COVID-19 and to improve normal immune cell function, in particular in elderly patients. Zinc may decrease the activity of the angiotensin converting enzyme 2, the receptor for SARS-CoV-2. Zinc T-cell modulation may down regulate the cytokine storm associated with severe COVID-19. Therefore, it may be suggested that Zn supplementation may be of potential support for treatment of COVID-19
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2021.v6.i3.pp17-20 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | A Review of Investigational Treatments for Covid-19 - Zinc Supplementary (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Dr. K. Deepa author: Dr. Preethi Anand author: Dr. S. Kothai publisher: Longman Publishers published: 2021-05-20 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 06 · no. 03 · pp. 17–20 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-09-12 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 25 references; 23 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Kumar A, Kubota Y, Chernov M, Kasuya H. Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Medical Hypotheses. 2020; 144: 109848 | 10.1016/j.mehy.2020.109848 | not held here |
| 2 | ref2 World Health Organization. Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019 nCoV. 2020. Available at: https://www.who.int/ith… | 10.2807/1560-7917.es.2020.25.5.200131e | not held here |
| 4 | ref4 Zumla A, Chan JF, Azhar EI et al. Coronaviruses—drug discovery and therapeutic options. Nat Rev Drug Discov. 2016; 15(5):327–347 | 10.1038/nrd.2015.37 | not held here |
| 5 | ref5 Abdulhamid I, Beck FW, Millard S, Chen X, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol. 2008; 43: 28… | 10.1002/ppul.20771 | not held here |
| 6 | ref6 Hemila H, Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017; 8: 2054270417694291 | 10.1177/2054270417694291 | not held here |
| 7 | ref7 Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984; 25: 20–24 | 10.1128/aac.25.1.20 | not held here |
| 8 | ref8 Philip MC, Tania A, Christopher P, Harish R, Simon J, Joseph R. Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalize… | 10.1101/2020.05.02.20080036 | not held here |
| 9 | ref9 Zhang L and Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020; 92: 479-490 | 10.1002/jmv.25707 | not held here |
| 10 | ref10 Hemila H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J 2011; 5: 51–58 | 10.2174/1874306401105010051 | not held here |
| 11 | ref11 SKALNY et al. Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). International Journal of Molecular Medicine. 2020 | 10.3892/ijmm.2020.4575 | not held here |
| 12 | ref12 Inga W, Benjamin R and Lothar R. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis Frontiers in Immunology. www.frontiersin.org. 2020; 11: 1712 | 10.3389/fimmu.2020.01712 | not held here |
| 13 | ref13 Amit K, Yuichi K, Mikhail C, Hidetoshi K. Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Medical Hypotheses. 2020; 144: 109848 | 10.1016/j.mehy.2020.109848 | not held here |
| 15 | ref15 Hemila H and Chalker E. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis. BMC Family Practice. 2015. 16: 24 | 10.1186/s12875-015-0237-6 | not held here |
| 16 | ref16 Petrus EJ, Lawson KA, Bucci LR, et al. Randomized, double-masked, placebo-controlled clinical study of the effec tiveness of zinc acetate lozenges on common cold symptoms in aller… | 10.1016/s0011-393x(98)85058-3 | not held here |
| 17 | ref17 SHORT COMMUNICATION Carlucci et al. Zinc sulfate in combination with a Zinc ionophore may improve outcomes in hospitalized COVID-19 patients. Journal of Medical Microbiology. 2020… | 10.1099/jmm.0.001250 | not held here |
| 18 | ref18 Eby GA. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Biosci Rep. 2004; 24: 23–39 | 10.1023/b:bire.0000037754.71063.41 | not held here |
| 19 | ref19 Eby GA. Zinc lozenges as cure for the common cold–a review and hypothesis. Med Hypotheses. 2010; 74: 482–492 | 10.1016/j.mehy.2009.10.017 | not held here |
| 20 | ref20 Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob A Review of Investigational Treatments for Covid-… | 10.1093/jac/20.6.893 | not held here |
| 21 | ref21 Smith AP, Tyrrell DA, Al-Nakib W, et al. Effects of zinc gluconate and nedocromil sodium on performance deficits produced by the common cold. J Psychopharmacol 1991; 5: 251–254 | 10.1177/026988119100500312 | not held here |
| 22 | ref22 Godfrey JC, Sloane BC, Smith DS, et al. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res. 1992; 20: 234–246 | 10.1177/030006059202000305 | not held here |
| 23 | ref23 Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996; 125: … | 10.7326/0003-4819-125-2-199607150-00001 | not held here |
| 24 | ref24 Eby GA, Davis DR and Halcomb WW. Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984; 25: 20–24 | 10.1128/aac.25.1.20 | not held here |
| 25 | ref25 Xue J, Moyer A, Peng B, Wu J, Hannafon BN et al. Chloroquine is a Zinc ionophore. PLoS One. 2014; 9 | 10.1371/journal.pone.0109180 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 135 fields set · sha256 cb009ae6004c… |
| 2 | 30 Sep 2026, 12:00 AM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 13 Sep 2026, 01:44 | Address updated from https://www.jst.org.in/index.php/pub/article/view/792/724 to https://www.jst.org.in/index.php/pub/article/view/792 | ● accepted by Crossref | 950406dc0323… |
| 15 Sep 2026, 20:21 | Read back: the DOI resolves to the new address | ● confirmed | dc080bacf850… |
| 15 Oct 2026, 15:30 | Metadata completed abstract (129 words) · licence | ● accepted by Crossref | cfedc3b72d4a… |
| 15 Oct 2026, 16:20 | Read back: Crossref's record shows it | ● confirmed | 78c44240f6cd… |
4 entries · the last fingerprint 78c44240f6cdf230ca3e01dee34041764e06d1b1852c3b23cc2c3b948c67b698 · the history as JSON, each entry with the fingerprint before it, to check them yourself.



